Department of Family and Consumer Studies, University of Utah, 225 South 1400 East Alfred Emery Building 228, Salt Lake City, UT 84112, USA.
Proc Biol Sci. 2012 Apr 7;279(1732):1389-95. doi: 10.1098/rspb.2011.1697. Epub 2011 Oct 12.
Women with BRCA1/2 mutations have a significantly higher lifetime risk of developing breast or ovarian cancer. We suggest that female mutation carriers may have improved fitness owing to enhanced fertility relative to non-carriers. Here we show that women who are carriers of BRCA1/2 mutations living in natural fertility conditions have excess fertility as well as excess post-reproductive mortality in relation to controls. Individuals who tested positive for BRCA1/2 mutations who linked into multi-generational pedigrees within the Utah Population Database were used to identify putative obligate carriers. We find that women born before 1930 who are mutation carriers have significantly more children than controls and have excess post-reproductive mortality risks. They also have shorter birth intervals and end child-bearing later than controls. For contemporary women tested directly for BRCA1/2 mutations, an era when modern contraceptives are available, differences in fertility and mortality persist but are attenuated. Our findings suggest the need to re-examine the wider role played by BRCA1/2 mutations. Elevated fertility of female mutation carriers indicates that they are more fecund despite their elevated post-reproductive mortality risks.
携带有 BRCA1/2 突变的女性一生中患乳腺癌或卵巢癌的风险显著增加。我们推测,由于相对非携带者的生育能力增强,女性突变携带者可能具有更好的适应性。在这里,我们发现生活在自然生育条件下的携带有 BRCA1/2 突变的女性,与对照组相比,具有额外的生育能力以及额外的生殖后死亡率。在犹他州人口数据库中通过多代系谱链接测试为 BRCA1/2 突变阳性的个体被用来识别可能的强制性携带者。我们发现,1930 年以前出生的携带有突变的女性比对照组生育的孩子明显更多,且具有更高的生殖后死亡风险。她们的生育间隔也更短,且比对照组更早停止生育。对于那些直接测试 BRCA1/2 突变的当代女性来说,在现代避孕药具可用的时代,生育能力和死亡率的差异仍然存在,但有所减弱。我们的研究结果表明,有必要重新审视 BRCA1/2 突变所扮演的更广泛的角色。女性突变携带者的生育能力升高表明,尽管她们的生殖后死亡率升高,但她们的生育能力更强。